title: Seizure and transient SIADH associated with sertraline.
authors.forename: L
authors.initials: L
authors.lastname: Goldstein
authors.forename: M
authors.initials: M
authors.lastname: Barker
authors.forename: F
authors.initials: F
authors.lastname: Segall
authors.forename: R
authors.initials: R
authors.lastname: Asihene
authors.forename: S
authors.initials: S
authors.lastname: Balser
authors.forename: D
authors.initials: D
authors.lastname: Lautenbach
authors.forename: M
authors.initials: M
authors.lastname: McCoy
mesh_terms: D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000209:etiology; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced* / Q000150:complications; D012640:Seizures / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline
chemical_list: D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline